During the past decade, Wojskowy Instytut Medyczny conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 22 clinical trials were completed, i.e. on average, 61.1% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 18 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wojskowy Instytut Medyczny" #1 sponsor was "Celgene" with 7 trials, followed by "Janssen Research & Development, LLC" with 7 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Takeda" with 4 trials sponsored and "Advanz Pharma" with 4 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wojskowy Instytut Medyczny" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "National Center for Research and Development, Poland" with 2 trials as a collaborator, "ABM Industries" with 1 trials as a collaborator, "ABX CRO" with 1 trials as a collaborator and "AG Mednet Inc." with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Wojskowy Instytut Medyczny" are "Crohn's Disease" (4 trials), "Atopic Dermatitis" (3 trials), "Atrial Fibrillation" (2 trials), "Colitis, Ulcerative" (2 trials) and "Multiple Sclerosis" (2 trials). Many other conditions were trialed in "Wojskowy Instytut Medyczny" in a lesser frequency.

Most popular intervention types in "Wojskowy Instytut Medyczny" are "Drug" (49 trials), "Other" (8 trials), "Biological" (5 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "Guselkumab" (5 trials), "Rituximab" (3 trials), "Baricitinib" (2 trials) and "Cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Wojskowy Instytut Medyczny" are 53 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Wojskowy Instytut Medyczny". undefined are not yet recruiting, 12 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Wojskowy Instytut Medyczny, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Wojskowy Instytut Medyczny, 1 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

Wojskowy Instytut Medyczny has several departments that took part in Clinical trials: "Wojskowy Instytut Medyczny; Klinika Onkologii" - 7 trials, "Wojskowy Instytut Medyczny, Klinika Dermatologiczna" - 3 trials, "Wojskowy Instytut Medyczny, Klinika Neurologiczna" - 2 trials, "Klinika Chorób Wewnętrznych i Hematologii Wojskowy Instytut Medyczny" - 2 trials